NO933742L - Humant, benavledet, insulinlignende vekstfaktorbindingsprotein - Google Patents

Humant, benavledet, insulinlignende vekstfaktorbindingsprotein

Info

Publication number
NO933742L
NO933742L NO933742A NO933742A NO933742L NO 933742 L NO933742 L NO 933742L NO 933742 A NO933742 A NO 933742A NO 933742 A NO933742 A NO 933742A NO 933742 L NO933742 L NO 933742L
Authority
NO
Norway
Prior art keywords
binding protein
insulin
human
igf
bone
Prior art date
Application number
NO933742A
Other languages
English (en)
Norwegian (no)
Inventor
Subburaman Mohan
David J Baylink
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO933742L publication Critical patent/NO933742L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO933742A 1991-04-19 1993-10-18 Humant, benavledet, insulinlignende vekstfaktorbindingsprotein NO933742L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19

Publications (1)

Publication Number Publication Date
NO933742L true NO933742L (no) 1993-10-18

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933742A NO933742L (no) 1991-04-19 1993-10-18 Humant, benavledet, insulinlignende vekstfaktorbindingsprotein

Country Status (11)

Country Link
EP (1) EP0580752A4 (fr)
JP (1) JP2527896B2 (fr)
KR (1) KR0129864B1 (fr)
AU (1) AU658187B2 (fr)
CA (1) CA2107475A1 (fr)
CZ (1) CZ283601B6 (fr)
FI (1) FI934588A0 (fr)
HU (1) HUT70297A (fr)
NO (1) NO933742L (fr)
RU (1) RU2114120C1 (fr)
WO (1) WO1992018154A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233155T2 (de) 1991-01-08 2004-06-03 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Insulinartigen wachstumsfaktor bindendes protein
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
EP0800530A4 (fr) * 1994-07-20 1998-12-02 Celtrix Pharma Complexe igf/igfbp destines a favoriser la formation osseuse et a reguler le remodelage osseux
ES2293137T3 (es) 1995-10-11 2008-03-16 Novartis Vaccines And Diagnostics, Inc. Combinacion de pdgf, kgf,igf e igfbp para curacion de heridas.
HUP0302525A2 (hu) 2001-01-05 2003-10-28 Abgenix, Inc. Az inzulinszerű növekedési faktor I receptor elleni ellenanyagok
US20190018025A1 (en) * 2015-12-31 2019-01-17 Siemens Healthcare Diagnostics Inc. Non-recombinant human insulin-like growth factor binding protein concentrate
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7907958A (nl) * 1979-10-30 1981-06-01 Wijn Adriaan Jacques De Kar of onderstel voorzien van opklapbare wielen.
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
ATE112684T1 (de) * 1987-04-28 1994-10-15 Boehringer Mannheim Gmbh Verwendung von igf-ii zur behandlung von knochenkrankheiten.

Also Published As

Publication number Publication date
JP2527896B2 (ja) 1996-08-28
CA2107475A1 (fr) 1992-10-20
JPH06501270A (ja) 1994-02-10
WO1992018154A1 (fr) 1992-10-29
AU1784492A (en) 1992-11-17
FI934588A (fi) 1993-10-18
KR0129864B1 (en) 1998-04-09
AU658187B2 (en) 1995-04-06
CZ219093A3 (en) 1994-12-15
EP0580752A4 (en) 1994-08-24
CZ283601B6 (cs) 1998-05-13
FI934588A0 (fi) 1993-10-18
HU9302942D0 (en) 1994-01-28
HUT70297A (en) 1995-09-28
EP0580752A1 (fr) 1994-02-02
RU2114120C1 (ru) 1998-06-27

Similar Documents

Publication Publication Date Title
ATE204176T1 (de) Verwendung von insulinähnlichen wachstumsfaktoren und analogen zur behandlung von erkrankungen der sehnerven
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE69231486D1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung
AU6184890A (en) Device for irradiating laser beams
BR9710536A (pt) Isobutilgaba e seus derivados para o tratamento da dor
ES2043890T3 (es) Nuevo uso medico.
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
DE3851776T2 (de) Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
AU3140589A (en) Composition inducing a binding
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
GR3000944T3 (en) Pharmaceutical composition containing thymus extract fractions
NO933742L (no) Humant, benavledet, insulinlignende vekstfaktorbindingsprotein
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
EP0339905A3 (fr) Composition cicatrisante contenant un facteur de croissance et des rétinoides
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
AU2534595A (en) Angiotensin ii for improving fertilization
EP0588477A3 (en) Medicinal composition comprising tcf-ii
DE3770766D1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
RU93058185A (ru) Фактор роста, композиция, способ модулирования действий фактора, способ лечения, способ доставки соединения, способы анализа
HU9300467D0 (en) Mixture of medical effect containing glutatione and antocithane derivatives
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ES2147519A1 (es) Utilizacion de un compuesto de tipo retinoide para modular in vivo la actividad desacopladora de la proteina ucp2.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application